Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province.

Jalalabadi Y, Shirazi A, Ghavam-Nasiri MR, Aledavood SA, Sardari D, Memar B, Shahidsales S, VarshoeeTabrizi F, Dehghan P, Vosughiniya H.

J Cancer Res Ther. 2018 Apr-Jun;14(3):509-515. doi: 10.4103/0973-1482.199428.

2.

Anti-tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer.

Javadinia SA, Gholami A, Joudi Mashhad M, Ferns GA, Shahidsales S, Avan A, Kermani AT.

J Cell Physiol. 2018 Oct;233(10):6523-6529. doi: 10.1002/jcp.26613. Epub 2018 May 9. Review.

PMID:
29741755
3.

The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer.

Rivandi M, Khorrami MS, Fiuji H, Shahidsales S, Hasanzadeh M, Jazayeri MH, Hassanian SM, Ferns GA, Saghafi N, Avan A.

J Cell Physiol. 2018 Jul;233(7):5170-5179. doi: 10.1002/jcp.26332. Epub 2018 Jan 23. Review.

PMID:
29240242
4.

Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.

Boromand N, Hasanzadeh M, ShahidSales S, Farazestanian M, Gharib M, Fiuji H, Behboodi N, Ghobadi N, Hassanian SM, Ferns GA, Avan A.

J Cell Physiol. 2018 Jun;233(6):4490-4496. doi: 10.1002/jcp.26232. Epub 2017 Nov 24. Review.

PMID:
29058790
5.

Efficacy and Safety of Pleurodesis Using Platelet-Rich Plasma and Fibrin Glue in Management of Postoperative Chylothorax After Esophagectomy.

Alamdari DH, Asadi M, Rahim AN, Maddah G, Azizi S, Shahidsales S, Mehrabibahar M.

World J Surg. 2018 Apr;42(4):1046-1055. doi: 10.1007/s00268-017-4242-x.

PMID:
28986682
6.

Targeted Therapies in Pancreatic Cancer: Promises and Failures.

Barati Bagherabad M, Afzaljavan F, ShahidSales S, Mahdi Hassanian S, Avan A.

J Cell Biochem. 2017 Jul 13. doi: 10.1002/jcb.26284. [Epub ahead of print]

PMID:
28703890
7.

Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.

Beheshti F, Hassanian SM, Khazaei M, Hosseini M, ShahidSales S, Hasanzadeh M, Maftouh M, Ferns GA, Avan A.

J Cell Physiol. 2018 Apr;233(4):2752-2758. doi: 10.1002/jcp.26091. Epub 2017 Aug 30. Review.

PMID:
28696006
8.

Head and Neck Cancers in North-East Iran: A 25 year Survey.

Emadzadeh M, Shahidsales S, Mohammadian Bajgiran A, Salehi M, Massoudi T, Nikfarjam Z, Salehi M.

Iran J Otorhinolaryngol. 2017 May;29(92):137-145.

9.

The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.

Bahrami A, Hassanian SM, Khazaei M, Hasanzadeh M, Shahidsales S, Maftouh M, Ferns GA, Avan A.

J Cell Biochem. 2018 Jan;119(1):111-122. doi: 10.1002/jcb.26183. Epub 2017 Jul 4. Review.

PMID:
28574616
10.

Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.

Bahrami A, Khazaei M, Hassanian SM, ShahidSales S, Joudi-Mashhad M, Maftouh M, Jazayeri MH, Parizade MR, Ferns GA, Avan A.

J Cell Physiol. 2018 Apr;233(4):2928-2936. doi: 10.1002/jcp.26041. Epub 2017 Jun 30. Review.

PMID:
28574572
11.

Genetic susceptibility in cervical cancer: From bench to bedside.

Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, Maftouh M, Gharib M, Yousefi Z, Kadkhodayan S, Ferns GA, Avan A.

J Cell Physiol. 2018 Mar;233(3):1929-1939. doi: 10.1002/jcp.26019. Epub 2017 Sep 7. Review.

PMID:
28542881
12.

The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.

Bahrami A, Khazaei M, Shahidsales S, Hassanian SM, Hasanzadeh M, Maftouh M, Ferns GA, Avan A.

J Cell Biochem. 2018 Jan;119(1):213-222. doi: 10.1002/jcb.26136. Epub 2017 Jul 4. Review.

PMID:
28513879
13.

The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy.

Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA, Avan A.

J Cell Biochem. 2017 Dec;118(12):4163-4169. doi: 10.1002/jcb.26118. Epub 2017 Jun 22. Review.

PMID:
28475243
14.

Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy.

Bahrami A, Amerizadeh F, Hassanian SM, ShahidSales S, Khazaei M, Maftouh M, Ghayour-Mobarhan M, Ferns GA, Avan A.

J Cell Physiol. 2018 Mar;233(3):2193-2201. doi: 10.1002/jcp.25966. Epub 2017 May 23. Review.

PMID:
28422287
15.

Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways.

Tajbakhsh A, Hasanzadeh M, Rezaee M, Khedri M, Khazaei M, ShahidSales S, Ferns GA, Hassanian SM, Avan A.

J Cell Physiol. 2018 Mar;233(3):2183-2192. doi: 10.1002/jcp.25961. Epub 2017 May 23. Review.

PMID:
28419458
16.

EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.

Anvari K, Sima HR, Seilanian Toussi M, Anvari A, Shahidsales S, Memar B, Aledavoud SA, Forghani MN, Abdollahi A, Ghaffarzadegan K.

Arch Iran Med. 2017 Apr;20(4):240-245. doi: 0172004/AIM.0010.

17.

Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer.

Bahrami A, Hasanzadeh M, ShahidSales S, Yousefi Z, Kadkhodayan S, Farazestanian M, Joudi Mashhad M, Gharib M, Mahdi Hassanian S, Avan A.

J Cell Biochem. 2017 Oct;118(10):3028-3033. doi: 10.1002/jcb.25992. Epub 2017 May 3. Review.

PMID:
28300286
18.

A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.

ShahidSales S, Mehramiz M, Ghasemi F, Aledavood A, Shamsi M, Hassanian SM, Ghayour-Mobarhan M, Avan A.

J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22190. Epub 2017 Mar 9.

PMID:
28276595
19.

The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.

Binabaj MM, Bahrami A, ShahidSales S, Joodi M, Joudi Mashhad M, Hassanian SM, Anvari K, Avan A.

J Cell Physiol. 2018 Jan;233(1):378-386. doi: 10.1002/jcp.25896. Epub 2017 May 16. Review.

PMID:
28266716
20.

Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.

Bahrami A, Hassanian SM, ShahidSales S, Farjami Z, Hasanzadeh M, Anvari K, Aledavood A, Maftouh M, Ferns GA, Khazaei M, Avan A.

J Cell Physiol. 2018 Mar;233(3):2058-2066. doi: 10.1002/jcp.25890. Epub 2017 May 23. Review.

PMID:
28262927
21.

Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.

Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, Sadeghnia HR, Rezayi M, Maftouh M, Hassanian SM, Avan A.

J Cell Biochem. 2018 Mar;119(3):2460-2469. doi: 10.1002/jcb.25950. Epub 2017 May 15.

PMID:
28230287
22.

Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.

Ebrahimi S, Hosseini M, Shahidsales S, Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM, Avan A.

Curr Med Chem. 2017;24(13):1321-1331. doi: 10.2174/0929867324666170206142658. Review.

PMID:
28176634
23.

GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.

Gholamin S, Mirzaei H, Razavi SM, Hassanian SM, Saadatpour L, Masoudifar A, ShahidSales S, Avan A.

J Cell Physiol. 2018 Feb;233(2):866-879. doi: 10.1002/jcp.25793. Epub 2017 May 23. Review.

PMID:
28145567
24.

Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer.

Shafiee M, Mohamadzade E, ShahidSales S, Khakpouri S, Maftouh M, Parizadeh SA, Hasanian SM, Avan A.

Curr Pharm Des. 2017;23(13):2002-2008. doi: 10.2174/1381612823666170123143648. Review.

PMID:
28117012
25.

Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.

Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, Maftouh M, Hassanian SM, Avan A.

J Cell Biochem. 2017 Aug;118(8):1979-1983. doi: 10.1002/jcb.25903. Epub 2017 Apr 25. Review.

PMID:
28109136
26.

The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.

Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A.

J Cell Physiol. 2018 Feb;233(2):774-786. doi: 10.1002/jcp.25813. Epub 2017 Mar 24. Review.

PMID:
28109133
27.

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

Hosseini M, Hassanian SM, Mohammadzadeh E, ShahidSales S, Maftouh M, Fayazbakhsh H, Khazaei M, Avan A.

J Cell Biochem. 2017 Jul;118(7):1634-1638. doi: 10.1002/jcb.25897. Epub 2017 Mar 15. Review.

PMID:
28106283
28.

The cross-regulation between SOX15 and Wnt signaling pathway.

Moradi A, Ghasemi F, Anvari K, Hassanian SM, Simab SA, Ebrahimi S, Hesari A, Forghanifard MM, Boroushaki MT, ShahidSales S, Avan A.

J Cell Physiol. 2017 Dec;232(12):3221-3225. doi: 10.1002/jcp.25802. Epub 2017 Mar 27. Review.

PMID:
28092101
29.

C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives.

Bahrami A, Shahidsales S, Khazaei M, Ghayour-Mobarhan M, Maftouh M, Hassanian SM, Avan A.

J Cell Physiol. 2017 Oct;232(10):2657-2673. doi: 10.1002/jcp.25794. Epub 2017 Apr 10. Review.

PMID:
28075018
30.

Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer.

Hosseini M, Khatamianfar S, Hassanian SM, Nedaeinia R, Shafiee M, Maftouh M, Ghayour-Mobarhan M, ShahidSales S, Avan A.

Curr Pharm Des. 2017;23(11):1705-1709. doi: 10.2174/1381612822666161201144634. Review.

PMID:
27908272
31.

Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran.

Anvari K, Seilanian Toussi M, Shahidsales S, Motlagh F, Reza Ehsaee M, Afshari F.

Iran J Cancer Prev. 2016 Mar 26;9(4):e4099. eCollection 2016 Aug.

32.

The Results of Chemotherapy with Two Variants of Intravenous CMF in Patients with Early Stage Breast Carcinoma; Does Dose Density Matter?

Salek R, Bayatmokhtari N, Homaei Shandiz F, ShahidSales S.

Breast J. 2016 Nov;22(6):623-629. doi: 10.1111/tbj.12652. Epub 2016 Aug 19.

PMID:
27540897
33.

Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.

Ebrahimi S, Hosseini M, Ghasemi F, Shahidsales S, Maftouh M, Akbarzade H, Parizadeh SA, Hassanian SM, Avan A.

Curr Pharm Des. 2016;22(42):6444-6450. doi: 10.2174/1381612822666160817095047. Review.

PMID:
27539232
34.

Changing pattern in the clinical presentation of breast cancer in the absence of a screening program over a period of thirty-three years in Iran.

Salek R, Shahidsales S, Mozafari V.

Breast. 2016 Aug;28:95-9. doi: 10.1016/j.breast.2016.05.003. Epub 2016 Jun 2.

PMID:
27262825
35.

Assessment of clinicopathologic features in patients with pituitary adenomas in Northeast of Iran: A 13-year retrospective study.

Anvari K, Kalantari MR, Samini F, Shahidsales S, Seilanian-Toussi M, Ghorbanpour Z.

Iran J Neurol. 2015 Oct 7;14(4):185-9.

36.

Role of SFRP1 in NPC Metastasis-Letter.

ShahidSales S, Hassanian SM, Mahdavian Zadeh R, Ghayour-Mobarhan M, Gholamin S, Ferns GA, Avan A.

Cancer Prev Res (Phila). 2016 May;9(5):415. doi: 10.1158/1940-6207.CAPR-15-0364. Epub 2016 Feb 15. No abstract available.

37.

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery.

Rajabi Mashhadi M, Bagheri R, Abdollahi A, Ghamari MJ, Shahidsales S, Salehi M, Shahkaram R, Majidi MR, Sheibani S.

Iran J Otorhinolaryngol. 2015 Jul;27(81):279-84.

38.

MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jaafari MR, Mirzaei HR, Hassanian SM, Avan A.

Eur J Cancer. 2016 Jan;53:25-32. doi: 10.1016/j.ejca.2015.10.009. Epub 2015 Dec 13. Review.

PMID:
26693896
39.

Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer.

Saeidi H, Nasiri MR, Shahidsales S, Kermani AT, Hematti S, Roodbari SS, Shahri MH, Chagharvand S.

Adv Biomed Res. 2015 Aug 31;4:177. doi: 10.4103/2277-9175.164013. eCollection 2015.

40.

Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer: The question is still open.

ShahidSales S, Mobarhan MG, Ghasemi F, Gholamin S, Avan A.

Cancer. 2015 Nov 1;121(21):3922-3. doi: 10.1002/cncr.29598. Epub 2015 Jul 28. No abstract available.

41.

A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP.

Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S.

Iran J Cancer Prev. 2015 Mar-Apr;8(2):84-8.

42.

Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer.

Avan A, Avan A, Maftouh M, Ghayour Mobarhan M, Shahidsales S, Gholamin S.

J Clin Oncol. 2015 May 20;33(15):1711-2. doi: 10.1200/JCO.2014.60.4702. Epub 2015 Apr 13. No abstract available.

PMID:
25870088
43.

The Prognostic Role of Tumor Marker CA-125 in B-Cell non-Hodgkin's Lymphoma.

Memar B, Aledavood A, Shahidsales S, Ahadi M, Farzadnia M, Raziee HR, Noori S, Tayebi-Meybodi N, Amouian S, Mohtashami S.

Iran J Cancer Prev. 2015 Jan-Feb;8(1):42-6.

44.

Evaluation of emotional distress in breast cancer patients.

Saeedi-Saedi H, Shahidsales S, Koochak-Pour M, Sabahi E, Moridi I.

Iran J Cancer Prev. 2015 Jan-Feb;8(1):36-41.

45.

Nevasic audio program for the prevention of chemotherapy induced nausea and vomiting: A feasibility study using a randomized controlled trial design.

Moradian S, Walshe C, Shahidsales S, Ghavam Nasiri MR, Pilling M, Molassiotis A.

Eur J Oncol Nurs. 2015 Jun;19(3):282-91. doi: 10.1016/j.ejon.2014.10.016. Epub 2014 Nov 4.

PMID:
25534959
46.

Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients--does it improve survival?

Saedi HS, Mansour-Ghanaei F, Joukar F, Shafaghi A, Shahidsales S, Atrkar-Roushan Z.

Asian Pac J Cancer Prev. 2014;15(20):8667-71.

47.

Vulvar carcinoma in pregnant women aged less than 40 years: case report.

Hasanzadeh M, Zamiri-Akhlaghi A, Hassanpoor-Moghaddam M, Shahidsales S.

Iran J Cancer Prev. 2014 Summer;7(3):175-8.

48.

Treatment Outcomes and Prognostic Factors in Pediatric Non-brainstem Astrocytoma in North East of Iran.

Anvari K, Seilanian Toussi M, Bahadorkhan G, Bitaghsir M, Heidari M, Fazl Ersi M, Shahidsales S.

Iran J Cancer Prev. 2014 Spring;7(2):96-100.

49.

Assessment of skin dose modification caused by application of immobilizing cast in head and neck radiotherapy.

Soleymanifard S, Toossi MT, Khosroabadi M, Noghreiyan AV, Shahidsales S, Tabrizi FV.

Australas Phys Eng Sci Med. 2014 Sep;37(3):535-40. doi: 10.1007/s13246-014-0283-8. Epub 2014 Jun 26.

PMID:
24964872
50.

Female genital tract tuberculosis presenting as ovarian cancer.

Hasanzadeh M, Naderi HR, Hoshyar AH, Shabane S, Shahidsales S.

J Res Med Sci. 2014 Feb;19(2):184-9.

Supplemental Content

Loading ...
Support Center